COMMUNIQUÉS West-GlobeNewswire

Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy
13/06/2018
FDA Approved, DBS Clinician Programmer Optimizes the Programming Experience By Addressing Day-to-Day Clinical Management Challenges DUBLIN - June 13, 2018 - Medtronic plc ( NYSE:MDT), the global leader in medical [...]
Revive Therapeutics and WeedMD Sign Medical Cannabis R&D Supply and Collaboration Agreements
13/06/2018
TORONTO, June 13, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”) , a company focused on the research, development and commercialization of novel cannabinoid-based [...]
Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting
13/06/2018
Results showed that oat avenanthramides supplementation reduce circulatory inflammation and inhibit expressions of chemokines and adhesion molecules EDMONTON, Alberta, June 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX- [...]
Akcea Announces Completion of Landmark Study to Assess Disease Burden in People Living with FCS
13/06/2018
Results published in Expert Review of Cardiovascular Therapy CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing [...]
Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference
13/06/2018
CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph. [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
13/06/2018
RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., June 13, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ:BCRX), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:IDRA), today announced that [...]
PetVivo Holdings, Inc. Adds Dr. Tracy Turner, Creates Veterinary Advisory Board
13/06/2018
MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKET:PETV), an emerging biomedical device company, is pleased to announce the addition of Dr. Tracy Turner of The Turner [...]
Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018
13/06/2018
LEXINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today late [...]
Avivagen Announces Distribution Agreement in Thailand
13/06/2018
OTTAWA, Ontario, June 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion [...]
Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft
13/06/2018
Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT ® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company Plans to Update 2018 [...]
Japanese Medical Agency (PMDA) supports the expansion of the Phase III program for PledOx® to include Japanese patients
13/06/2018
Stockholm, June 13, 2018. PledPharma AB and Solasia Pharma K.K. (Solasia) today announced that the Japanese Pharmaceuticals and Medical Devices Agency, PMDA, following a meeting with PledPharma and Solasia, has [...]
Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner
13/06/2018
Orion Corporation Press release 13 June 2018 at 9.00 a.m. Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner Orion and the John Nurminen Foundation have signed an agreement on the [...]
Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema
13/06/2018
Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema Herantis Pharma Plc Company release 13 Jun 2018 at 9:00 am Herantis Pharma Plc ("Herantis") announced today the [...]
Shire plc : Rule 2.9 Announcement
13/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 June 2018 Shire [...]
Novartis presents data to advance understanding of the role of IL-17A and reinforce Cosentyx® leadership in spondyloarthritis
13/06/2018
26 abstracts on Cosentyx ® (secukinumab) in ankylosing spondylitis (AS) and psoriatic arthritis (PsA) will be presented at the Annual European Congress of Rheumatology (EULAR 2018 )[1] Breadth of data covers updates on [...]
Sanofi : Sanofi successfully prices USD 2 billion bond issue
13/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi successfully prices USD 2 billion bond issue Paris, France - June 13, 2018 - Sanofi has successfully priced its offering of USD 2 billion of notes [...]
Sanofi : Sanofi place un emprunt obligataire de 2 milliards de dollars
13/06/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi place un emprunt obligataire de 2 milliards de dollars Paris, France - Le 13 juin 2018 - Sanofi a placé avec succès une émission obligataire en 2 [...]
TiGenix announces a change in its Board of Directors and its Management Team
13/06/2018
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix announces a change in its Board of Directors and its Management Team Leuven (Belgium) - June 13, 2018, 07:00h CEST - TiGenix NV (Euronext Brussels and [...]
TiGenix annonce un changement dans son conseil d'administration et son équipe de direction
13/06/2018
COMMUNIQUÉ DE PRESSE INFORMATION RÈGLEMENTÈE INFORMATION PRIVILÉGIÉE TiGenix annonce un changement dans son conseil d'administration et son équipe de direction Louvain (Belgique) - 13 juin 2018, 7:00h CEST - TiGenix NV [...]

Pages